- $2.07bn
- $1.54bn
- $874.18m
- 94
- 40
- 98
- 92
Annual balance sheet for Argan, fiscal year end - January 31st, USD millions except per share, conversion factor applied.
2021 January 31st | 2022 January 31st | 2023 January 31st | 2024 January 31st | 2025 January 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 457 | 440 | 325 | 412 | 525 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 55.3 | 31.9 | 74.9 | 95.5 | 240 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 546 | 507 | 439 | 547 | 781 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 24.1 | 14.5 | 16.5 | 18.5 | 24.5 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Other Long Term Assets | |||||
Total Assets | 603 | 554 | 489 | 598 | 836 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 276 | 223 | 203 | 302 | 480 |
Total Long Term Debt | |||||
Total Debt | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Liabilities | 282 | 227 | 209 | 307 | 484 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Other Equity | |||||
Total Equity | 321 | 326 | 281 | 291 | 352 |
Total Liabilities & Shareholders' Equity | 603 | 554 | 489 | 598 | 836 |
Total Common Shares Outstanding |